They include upregulation of RhoA and ROCK1 expression [69,70,71], acquiring activating mutations of ROCK1 in microsatellite-instable colon cancer [72], as well as frequent inactivating mutations of upstream negative regulators of RhoA, Rho GTPase-activating proteins [73]. This evidence concerns the gene ROCK1 and colonic neoplasm.